(Q43461322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

9

Dennis M Black

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Ann V Schwartz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Anne L Schafer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Andrew Grey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Eric Vittinghoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lisa Palermo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Li-Yung L Lui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Robert B Wallace

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Steven R Cummings

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Douglas C Bauer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1348-1354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

22 February 2020

cites work

1 reference

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

Vitamin K-dependent carboxylation of osteocalcin: friend or foe?

21 January 2018

1 reference

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

21 January 2018

1 reference

The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women

21 January 2018

1 reference

Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy

21 January 2018

1 reference

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

21 January 2018

1 reference

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

21 January 2018

1 reference

Bone and glucose metabolism: a two-way street

21 January 2018

1 reference

Association between serum osteocalcin and markers of metabolic phenotype

21 January 2018

1 reference

Effect of vitamin K supplementation on insulin resistance in older men and women

21 January 2018

1 reference

Gamma-carboxylation of osteocalcin and insulin resistance in older men and women

21 January 2018

1 reference

A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort

21 January 2018

1 reference

Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study

21 January 2018

1 reference

Design of the Fracture Intervention Trial

21 January 2018

1 reference

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

21 January 2018

1 reference

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

21 January 2018

1 reference

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

21 January 2018

1 reference

Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption.

21 January 2018

1 reference

Epidemiologic trends in overweight and obesity

21 January 2018

1 reference

Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians

21 January 2018

1 reference

The Danish National Diabetes Register: trends in incidence, prevalence and mortality

21 January 2018

1 reference

Socioeconomic position and the incidence of type 2 diabetes: the ELSA study

21 January 2018

1 reference

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

21 January 2018

1 reference

Effect of phylloquinone supplementation on glucose homeostasis in humans

21 January 2018

1 reference

The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study

21 January 2018

1 reference

Effect of osteoporosis treatment on mortality: a meta-analysis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.1865

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23322676%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference